{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:01:41Z","timestamp":1790722901938,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["BOMBER19R0"],"award-info":[{"award-number":["BOMBER19R0"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR002490"],"award-info":[{"award-number":["KL2TR002490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["K23HL131930"],"award-info":[{"award-number":["K23HL131930"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["ZEMKE16Q0"],"award-info":[{"award-number":["ZEMKE16Q0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["ZEMKE19A0"],"award-info":[{"award-number":["ZEMKE19A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jcf.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T14:12:49Z","timestamp":1647267169000},"page":"792-799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Amanda L.","family":"Stapleton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Kimple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Goralski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Mehdi","family":"Nouraie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barton F","family":"Branstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber D","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M","family":"Pilewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella E","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Zemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2022.03.002_bib0001","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/00005537-199608000-00018","article-title":"Patterns of sinusitis in cystic fibrosis","volume":"106","author":"Gentile","year":"1996","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcf.2022.03.002_bib0002","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1007\/s00405-014-3446-z","article-title":"Nasal endoscopy and paranasal sinus computerised tomography (CT) findings in an Irish cystic fibrosis adult patient group","volume":"272","author":"Casserly","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0003","first-page":"108","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis","volume":"8","author":"Wise","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijporl.2019.05.030","article-title":"Evolution of sinonasal clinical features in children with cystic fibrosis","volume":"124","author":"Suy","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.iac.2019.12.008","article-title":"Management of sinusitis in the cystic fibrosis patient","volume":"40","author":"Okafor","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jcf.2022.03.002_bib0006","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/lio2.401","article-title":"Chronic rhinosinusitis in patients with cystic fibrosis\u2014current management and new treatments","volume":"5","author":"Johnson","year":"2020","journal-title":"Laryngoscope Invest Otolaryngol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0007","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1513\/AnnalsATS.201408-393OC","article-title":"Association between chronic rhinosinusitis and health-related quality of life in adults with cystic fibrosis","volume":"12","author":"Habib","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2022.03.002_bib0008","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00405-016-4426-2","article-title":"Sinonasal characteristics and quality of life by SNOT-22 in adult patients with cystic fibrosis","volume":"274","author":"Kang","year":"2017","journal-title":"Eur Archiv Oto-Rhino-Laryngol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0009","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamaoto.2016.0979","article-title":"Sinonasal quality of life in children with cystic fibrosis","volume":"142","author":"Chan","year":"2016","journal-title":"JAMA Otolaryngol\u2013Head Neck Surg"},{"key":"10.1016\/j.jcf.2022.03.002_bib0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1164\/rccm.201312-2129PP","article-title":"The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography","volume":"189","author":"Whiteson","year":"2014","journal-title":"Am J Respirat Crit Care Med"},{"key":"10.1016\/j.jcf.2022.03.002_bib0011","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/alr.22043","article-title":"Pulmonary aspiration of sinus secretions in patients with cystic fibrosis","volume":"8","author":"Nelson","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0012","article-title":"Clinical predictors of cystic fibrosis chronic rhinosinusitis severity","author":"Zemke Anna","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0013","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/alr.22485","article-title":"Sinonasal quality-of-life declines in cystic fibrosis patients with pulmonary exacerbations","volume":"10","author":"Safi","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcf.2011.09.009","article-title":"CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients","volume":"11","author":"Rasmussen","year":"2012","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2022.03.002_bib0015","doi-asserted-by":"crossref","unstructured":"Derycke L., Eyerich S., Crombruggen K.v., P\u00e9 Rez-Novo C., Holtappels G., Deruyck N., et\u00a0al. Mixed T helper cell signatures In chronic rhinosinusitis with and without Polyps n.d. doi:10.1371\/journal.pone.0097581.","DOI":"10.1371\/journal.pone.0097581"},{"key":"10.1016\/j.jcf.2022.03.002_bib0016","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ppul.23613","article-title":"Importance to question sinonasal symptoms and to perform rhinoscopy and rhinomanometry in cystic fibrosis patients","volume":"52","author":"Bock","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0017","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/alr.21440","article-title":"Medical reversal of chronic sinusitis in a cystic fibrosis patient with ivacaftor","volume":"5","author":"Chang","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0018","article-title":"Ivacaftor improves rhinologic, psychologic, and sleep-related quality of life in G551D cystic fibrosis patients","author":"McCormick","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2020.07.002","article-title":"Effect of highly effective modulator treatment on sinonasal symptoms in cystic fibrosis","volume":"20","author":"DiMango","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.03.002_bib0020","article-title":"Impact of CFTR therapy on chronic rhinosinusitis and health status: deep learning CT analysis and patient reported outcomes","author":"Beswick","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2022.03.002_bib0021","article-title":"Olfaction before and after initiation of Elexacaftor-Tezacaftor-Ivacaftor in a cystic fibrosis cohort","author":"Bacon","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0022","article-title":"Olfactory dysfunction in cystic fibrosis: impact of CFTR modulator therapy","author":"DM","year":"2021","journal-title":"J Cystic Fibrosi"},{"key":"10.1016\/j.jcf.2022.03.002_bib0023","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item sinonasal outcome test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0024","first-page":"1985","article-title":"Evaluation of chronic rhinosinusitis management using the SNOT-22 in adult cystic fibrosis patients","volume":"18","author":"Savastano","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jcf.2022.03.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-4486.2009.01975.x","article-title":"A pilot study of the SNOT 22 score in adults with no sinonasal disease","volume":"34","author":"Gillett","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0026","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","article-title":"Staging for rhinosinusitis","volume":"117","author":"Lund","year":"1997","journal-title":"Otolaryngol\u2013Head Neck Surg"},{"key":"10.1016\/j.jcf.2022.03.002_bib0027","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2500\/ajr.2007.21.2905","article-title":"The delta F508 mutation in cystic fibrosis and impact on sinus development","volume":"21","author":"Woodworth","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0028","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ijporl.2015.06.007","article-title":"Lund-Mackay and modified Lund-Mackay score for sinus surgery in children with cystic fibrosis","volume":"79","author":"Do","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jcf.2022.03.002_bib0029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jcf.2022.03.002_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/000348949510410s02","article-title":"Quantification for staging sinusitis. The staging and therapy group","volume":"167","author":"Lund","year":"1995","journal-title":"Annal Otol Rhinol Laryngol Suppl"},{"key":"10.1016\/j.jcf.2022.03.002_bib0031","article-title":"VX445\u2013Tezacaftor\u2013ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","author":"Uluer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2022.03.002_bib0032","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/lary.27595","article-title":"Impact of high- versus low-risk genotype on sinonasal radiographic disease in cystic fibrosis","volume":"129","author":"Halderman","year":"2019","journal-title":"Laryngoscope"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:46:41Z","timestamp":1761601601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1569199322000510"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.03.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}